Agensys' Series B Round

Agensys raised a round of funding on October 15, 1999. Investors include LODH Private Equity Partners.

Agensys, Inc. is developing a pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers based on its own proprietary targets. The Company has discovered and validat…

Articles about Agensys' Series B Round: